Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations.

Erinn S Kellner,Christa Krupski,Hye Sun Kuehn,Sergio D Rosenzweig,Nao Yoshida,Seiji Kojima,David Boutboul,Sylvain Latour,Vincent Barlogis,Claire Galambrun,Asbjørg Stray-Pedersen,Hans Christian Erichsen,Rebecca A Marsh

The Journal of allergy and clinical immunology（2019）

引用 15|浏览93

暂无评分

摘要

Allogeneic hematopoietic cell transplantation for patients with dominant-negative IKZF1/IKAROS mutations is not associated with unusually high risks of acute graft versus host disease or mortality.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要